Responsabile dell'U.O.
Cognome e Nome
Alberto Passi
Qualifica
PO
Dipartimento
Department of Medicine and Surgery (DMC)
Settore scientifico disciplinare
BIO/10
alberto.passi@uninsubria.it
Telefono
Personale strutturato
Cognome e Nome
Karousou Evgenia
Qualifica
PA
Dipartimento
Department of Medicine and Surgery (DMC)
Ente di appartenenza
University of Insubria Varese
Cognome e Nome
Moretto Paola
Qualifica
Technician
Dipartimento
Department of Medicine and Surgery (DMC)
Ente di appartenenza
University of Insubria Varese
Cognome e Nome
Pallotti Francesco
Qualifica
PA
Dipartimento
Department of Medicine and Surgery (DMC)
Ente di appartenenza
University of Insubria Varese
Cognome e Nome
Vigetti Davide
Qualifica
PA
Dipartimento
Department of Medicine and Surgery (DMC)
Ente di appartenenza
University of Insubria Varese
Cognome e Nome
Viola Manuela
Qualifica
PA
Dipartimento
Department of Medicine and Surgery (DMC)
Ente di appartenenza
University of Insubria Varese
Personale non strutturato
Cognome e Nome
Arianna Parnigoni
Qualifica
Post-doc
Dipartimento
Department of Medicine and Surgery (DMC)
Ente di appartenenza
University of Insubria Varese
Linee di ricerca
The main interest of the Passi’s group is the glycosaminoglycan (GAG) metabolism with particular attention to hyaluronic acid. GAGs are linear sulphated polysaccharides containing uronic acid and hexosamine residues. These molecules are very common in nature and linked to a protein core constitute the proteoglycan family. Hyaluronan (HA) is a special GAG without core protein and completely unsulphated. The aim of our work is the study of the mechanisms driving the GAG synthesis. In order to achieve this target we use a biochemical approach integrated with molecular biology techniques and morphology. To address the GAG chemistry we set up a new electrophoretic method based on the carbohydrate fluorescence (FACE). This method is very simple, fast and able to detect few pmoles of samples. Our preliminary data indicate that over expression in cells of UGDH, the enzyme involved in the synthesis of UDP-glucuronic acid (UDPGlcUA), the UDP uronic precursors of all GAGs, induced an increase in the cells of this precursor and consequently an increase of HA synthesis. On the other hand the silencing of the same enzyme by siRNA induced in the cells the opposite effect, confirming that the availability of UDPGlcUA controls the HA synthesis. In order to quantify the UDP sugars precursors in the cells, we developed a method using HPLC able to separate and quantify all UDP sugars involved in GAG synthesis. Moreover, the altered UDP sugar concentration in the cells was able to alter the expression of the enzymes involved in the UDP sugars synthesis and even the enzymes involved in GAG synthesis. On this basis we are now elucidating the mechanisms involved in this control of enzymes of the pathway of GAG synthesis. For this purpose we also consider the post transcriptional modification of the enzymes using a proteomic approach based on bi-dimensional electrophoresis and mass spectrometry analysis coupled with a genomic approach base on the microarray chips and real time RT-PCR.
Tecnologie in uso dall'UO
- HPLC and carbohydrate
- FACE electrophoresis for carbohydrate
- Confocal Cell Fluorescence
- Cell cultures
- Transient transfection by nucleofection
- Signal silencing using siRNA
- Cell membrane impedance (ECIS).
- Carbohydrate Mass spectrometry
- Real time RT-PCR
Strumentazione
Denominazione
Real time PCR
Ultracentrifuge
HPLC/FPLC with fluorescence detector
Nucleofector and cell cultures
Inverted Fluorescence microscopy
Multiwavelength Fluorescence plate reader
Struttura ove la strumentazione è allocata
Pad. Bassani
Pad. Bassani
Pad. Bassani
Pad. Bassani
Pad. Bassani
Pad. Bassani
Responsabile
Passi
Moretto
Viola
Vigetti
Karousou
Moretto
Pubblicazioni
- Passi, A., Vigetti, D. (2019). Hyaluronan as tunable drug delivery system. Advanced Drug Delivery 146, pp. 83-96
- Karamanos NK, Piperigkou Z, Theocharis AD, Watanabe H, Franchi M, Baud S, Brézillon S, Götte M, Passi A, Vigetti D, Ricard-Blum S, Sanderson RD, Neill T, Iozzo RV (2018) Proteoglycan Chemical Diversity Drives Multifunctional Cell Regulation and Therapeutics. Chem Rev. 118:9152-9232.
- Viola M, Karousou E, D'Angelo ML, Moretto P, Caon I, Luca G, Passi A, Vigetti D. (2017) Extracellular Matrix in Atherosclerosis: Hyaluronan and Proteoglycans Insights. Curr Med Chem. 23:2958-2971
- Vigetti D, Deleonibus S, Moretto P, Bowen T, Fischer JW, Grandoch M, Oberhuber A, Love DC, Hanover JA, Cinquetti R, Karousou E, Viola M, D’Angelo ML, HAscall VC, De Luca G, Passi A (2014) Natural antisense transcript for hyaluronan synthase 2 (HAS2-AS1) induces transcription of HAS2 via protein O-GlcNAcylation. J Biol Chem. 289:28816-28826 (comment on Matrix Biology highlights)
- Vigetti D, Karousou E, Viola M, Deleonibus S, De Luca G, Passi A (2014) Hyaluronan: biosynthesis and signaling. Biochim Biophys Acta - General Subjects 1840: 2452-2459
Dottorati di ricerca
Componente UO
Davide Vigetti
Manuela Viola
Dottorato di ricerca
Scienze della Vita e Biotecnologie
Scienze della Vita e Biotecnologie
Coordinatore
Silvia Sacchi
Silvia Sacchi
Sede
Varese
Varese